2027 ICD-10-CM Diagnosis Code F18.180Inhalant abuse with inhalant-induced anxiety disorder

ICD-10-CM Codes›F01–F99›F10-F19›F18

ICD-10-CM F18.180
CMSSource: CMS FY 2027 ICD-10-CM dataset · Effective Oct 1, 2026 – Sep 30, 2027

F18.180 is a billable ICD-10-CM diagnosis code for inhalant abuse with inhalant-induced anxiety disorder. It is valid on HIPAA claims for fiscal year 2027 (October 1, 2026 through September 30, 2027) and groups to MS-DRG 894 through 897. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Anxiety and fear-related disorders and Inhalant-related disorders.

For Medicare Advantage risk adjustment, F18.180 maps to CMS-HCC Category 137 (Drug Use Disorder, Moderate/Severe, or Drug Use with Non-Psychotic Complications) under the V28 model, adding a risk factor of about 0.424 for a community, non-dual, aged beneficiary in payment year 2027.

Code Identity

ICD-10-CM Code
F18.180
Billable Status
Yes — Valid for Submission
Code Describes
Inhalant abuse with inhalant-induced anxiety disorder
Short Description
Inhalant abuse with inhalant-induced anxiety disorder
Same as the full description in the CMS dataset.
Parent Code
Inhalant abuse with other inhalant-induced disorders

Code Classification

ChapterF01–F99Mental and behavioural disorders
SectionF10-F19Mental and behavioral disorders due to psychoactive substance use
CategoryF18Inhalant related disorders
This CodeF18.180Inhalant abuse with inhalant-induced anxiety disorder

Medicare Risk Adjustment (HCC)Billing

F18.180 maps to a payment category in the CMS-HCC model used to risk-adjust Medicare Advantage payments. Weights are the published community factors for payment year 2027.

CMS-HCC V28 Category (Payment Model)
HCC 137— Drug Use Disorder, Moderate/Severe, or Drug Use with Non-Psychotic Complications
Payment HCC · PY 2027 one of 308 ICD-10-CM codes in this category
Risk Adjustment Factor (RAF) Weight
+0.424
community, non-dual, aged · ranges 0.297–0.502 across segments
Hierarchy
Superseded by HCC 135 and HCC 136
a more severe related category takes the payment when both are reported
Prior Model (CMS-HCC V24)
HCC 55
V24 retired V28 pays 100% of MA risk scores since PY 2026
Other CMS Models
PACE (CMS-HCC V22): HCC 55 · ESRD (V21): HCC 55 · ESRD (V24): HCC 55
ESRD V21 weights: 0.048 dialysis, 0.112–0.352 functioning graft · ESRD V24 weights: 0.111 dialysis, 0.172–0.416 functioning graft
Part D (RxHCC)
Not mapped
F18.180 does not risk-adjust in the RxHCC prescription drug model

Source: CMS Payment Year 2027 risk adjustment mappings and model software. Weights are relative factors, not dollar amounts; a beneficiary's total RAF also includes demographics and interactions. Browse all CMS-HCC categories.

Instructional NotesGuidance

Instructions from the official ICD-10-CM Tabular List that apply to F18.180: its own notes plus those printed at F18.1, F18, and Chapter 5. A note printed at a category, block or chapter applies to every code under it.

Includes

Further defines, or gives examples of, the content of the category.

From F18 Inhalant related disorders applies to 39 codes
  • volatile solvents
From Chapter 5 (F01-F99) Mental and behavioural disorders applies to 872 codes
  • disorders of psychological development

Excludes1

Not coded here: the excluded code is never reported together with this one, unless the two conditions are unrelated.

From F18.1 Inhalant abuse applies to 13 codes
  • inhalant dependence (F18.2-)
  • inhalant use, unspecified (F18.9-)

Excludes2

Not included here: the excluded condition is not part of this code, but a patient may have both, so both codes may be reported.

From Chapter 5 (F01-F99) Mental and behavioural disorders applies to 872 codes
  • symptoms, signs and abnormal clinical laboratory findings, not elsewhere classified (R00-R99)

Source: CMS ICD-10-CM Tabular List. How to read instructional notes.

Referenced in Other NotesGuidance

Instructional notes printed at other codes that name F18.180, its category, or a range that includes it.

Excludes1 2

These codes carry an Excludes1 note naming F18.180: they are not reported together with it, unless the two conditions are unrelated.

  • F18.2 Inhalant dependence
    inhalant abuse (F18.1-) names F18.1-, which includes this code
  • F18.9 Inhalant use, unspecified
    inhalant abuse (F18.1-) names F18.1-, which includes this code

Index to Diseases and InjuriesGuidance

Clinical ClassificationClinical

AHRQ’s CCSR groups this code into broader clinical categories.

CCSR MBD005
Anxiety and fear-related disorders
Default principal diagnosis: inpatient No · outpatient No
CCSR MBD023
Inhalant-related disorders
Default principal diagnosis: inpatient Yes · outpatient Yes

Clinical InformationClinical

  • Inhalant Abuse

    illicit use of chemicals and products whose vapors can be inhaled to produce a rapid mind-altering effect. inhalants include aerosols, gases, and volatile solvents that are often inhaled repeatedly to achieve the short-lived intoxicating effect.

Patient EducationClinical

Anxiety

Anxiety is a feeling of fear, dread, and uneasiness. It might cause you to sweat, feel restless and tense, and have a rapid heartbeat. It can be a normal reaction to stress. For example, you might feel anxious when faced with a difficult problem at work, before taking a test, or before making an important decision.

The full article covers:

  • What is anxiety?
  • What are anxiety disorders?
  • What are the types of anxiety disorders?
  • What causes anxiety disorders?
  • Who is at risk for anxiety disorders?
  • What are the symptoms of anxiety disorders?
  • How are anxiety disorders diagnosed?
  • What are the treatments for anxiety disorders?

Read the full article at MedlinePlus

Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.

Convert F18.180 to ICD-9-CMHistory

The closest ICD-9-CM equivalents under the General Equivalence Mappings.

ICD-9-CM
292.89 Drug mental disorder NEC
Approximate The match is approximate rather than exact.

Code HistoryHistory

FY 2016AddedAdded to the ICD-10-CM code setEffective October 1, 2015, the first year of ICD-10-CM.
FY 2017–2026No changes
FY 2027CurrentCurrent code set, no changesEffective October 1, 2026 through September 30, 2027.

Questions About F18.180Overview

What is the ICD-10 code for inhalant abuse with inhalant-induced anxiety disorder?

The ICD-10-CM code for inhalant abuse with inhalant-induced anxiety disorder is F18.180 (sometimes written as F18180). It is billable on HIPAA-covered claims from October 1, 2026 through September 30, 2027.

Is F18.180 (Inhalant abuse with other inhalant-induced disorders) a billable code?

Yes. This is a billable ICD-10-CM code, specific enough to report inhalant abuse with inhalant-induced anxiety disorder on HIPAA-covered claims from October 1, 2026 through September 30, 2027.

What MS-DRG does F18.180 group to?

When inhalant abuse with inhalant-induced anxiety disorder is the principal diagnosis on an inpatient stay, it groups to MS-DRG 894, 897, 895, 896, with relative weights from 0.6272 to 1.6610 depending on complications. Higher weights mean higher Medicare reimbursement.

Can F18.180 be reported with a code from F18.2?

Not as a rule. The Excludes1 note at F18.1, which applies to F18.180, lists "inhalant dependence (F18.2-)". An Excludes1 note means the excluded code is never reported together with this one; the only exception is when the two conditions are unrelated to each other (Official Guidelines, Section I.A.12.a).

What is the ICD-9 equivalent of F18.180?

Under the General Equivalence Mappings, inhalant abuse with inhalant-induced anxiety disorder converts to ICD-9-CM 292.89 (drug mental disorder NEC). The mapping is approximate, so confirm the match fits the documentation.

What HCC is F18.180?

F18.180 (inhalant abuse with inhalant-induced anxiety disorder) maps to CMS-HCC Category 137 (Drug Use Disorder, Moderate/Severe, or Drug Use with Non-Psychotic Complications), commonly written as HCC 137, in the CMS-HCC V28 model used for Medicare Advantage risk adjustment in payment year 2027. It mapped to HCC 55 under the retired V24 model. It also maps in the PACE (CMS-HCC V22), ESRD (V21), and ESRD (V24) models. It does not map to any RxHCC in the Part D prescription drug model.

Does F18.180 risk-adjust for Medicare Advantage payment?

Yes. When documented and reported on a Medicare Advantage encounter, F18.180 adds a risk adjustment factor of about 0.424 to the beneficiary's RAF score for a community, non-dual, aged enrollee (published V28 weights range from 0.297 to 0.502 depending on the payment segment). A more severe related category (HCC 135 and HCC 136) supersedes it when both are reported. See the full factor table on the HCC 137 category page.